Cargando…

Optimization of growth of Levilactobacillus brevis SP 48 and in vitro evaluation of the effect of viable cells and high molecular weight potential postbiotics on Helicobacter pylori

Several Levilactobacillus brevis strains have the potential to be used as probiotics since they provide health benefits due to the interaction of live cells, and of their secreted products, with the host (tissues). Therefore, the development of simple fermentation processes that improve cell viabili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cimini, Donatella, D’ambrosio, Sergio, Stellavato, Antonietta, Fusco, Alessandra, Corsaro, Maria Michela, Dabous, Azza, Casillo, Angela, Donnarumma, Giovanna, Giori, Andrea Maria, Schiraldi, Chiara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Bioengineering and Biotechnology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9661962/ https://www.ncbi.nlm.nih.gov/pubmed/36394050 http://dx.doi.org/10.3389/fbioe.2022.1007004

Ejemplares similares

Limosilactobacillus fermentum from buffalo milk is suitable for potential biotechnological process development and inhibits Helicobacter pylori in a gastric epithelial cell model
por: D'ambrosio, Sergio, et al.
Publicado: (2022)

Lead biosorption efficiency of Levilactobacillus brevis MZ384011 and Levilactobacillus brevis MW362779: A response surface based approach
por: Mushtaq, Maria, et al.
Publicado: (2023)

Immunomodulatory Properties of a γ-Aminobutyric Acid-Enriched Strawberry Juice Produced by Levilactobacillus brevis CRL 2013
por: Cataldo, Pablo G., et al.
Publicado: (2020)

Surface Layer Protein Pattern of Levilactobacillus brevis Strains Investigated by Proteomics
por: Mazzeo, Maria Fiorella, et al.
Publicado: (2022)

Genome Sequences for Levilactobacillus brevis Autochthonous to Commercial Cucumber Fermentations
por: Page, Clinton A., et al.
Publicado: (2022)

Complete Genome Sequence of Levilactobacillus brevis Bacteriophage ENFP1
por: Kim, Jena, et al.
Publicado: (2022)

In Vitro Evaluation of the Most Active Probiotic Strains Able to Improve the Intestinal Barrier Functions and to Prevent Inflammatory Diseases of the Gastrointestinal System
por: Fusco, Alessandra, et al.
Publicado: (2023)

Sodium-Ion-Free Fermentative Production of GABA with Levilactobacillus brevis CD0817
por: Li, Haixing, et al.
Publicado: (2023)

The effects of Levilactobacillus brevis on the physiological parameters and gut microbiota composition of rats subjected to desynchronosis
por: Olekhnovich, Evgenii I., et al.
Publicado: (2021)

Gamma-Aminobutyric Acid-Producing Levilactobacillus brevis Strains as Probiotics in Litchi Juice Fermentation
por: Jin, Yiwen, et al.
Publicado: (2023)

Levilactobacillus brevis with High Production of Putrescine Isolated from Blue Cheese and Its Application
por: Ami, Yuta, et al.
Publicado: (2023)

Complete Lipooligosaccharide Structure from Pseudoalteromonas nigrifaciens Sq02-Rif(r) and Study of Its Immunomodulatory Activity
por: Di Guida, Rossella, et al.
Publicado: (2021)

β-Glucan Production by Levilactobacillus brevis and Pediococcus claussenii for In Situ Enriched Rye and Wheat Sourdough Breads
por: Bockwoldt, Julia A., et al.
Publicado: (2021)

Immune-Enhancing Effect of Heat-Treated Levilactobacillus brevis KU15159 in RAW 264.7 Cells
por: Hwang, Chang-Hoon, et al.
Publicado: (2022)

In Vivo Evaluation of Immune-Enhancing Activity of Red Gamju Fermented by Probiotic Levilactobacillus brevis KU15154 in Mice
por: Park, Eunju, et al.
Publicado: (2021)

Proteomic Analysis Reveals Enzymes for β-D-Glucan Formation and Degradation in Levilactobacillus brevis TMW 1.2112
por: Bockwoldt, Julia A., et al.
Publicado: (2022)

Probiotic and Antifungal Attributes of Levilactobacillus brevis MYSN105, Isolated From an Indian Traditional Fermented Food Pozha
por: Somashekaraiah, Rakesh, et al.
Publicado: (2021)

The Production of γ-Aminobutyric Acid from Free and Immobilized Cells of Levilactobacillus brevis Cultivated in Anaerobic and Aerobic Conditions
por: Zotta, Teresa, et al.
Publicado: (2022)

Prevention of Fungal Contamination in Semi-Hard Cheeses by Whey–Gelatin Film Incorporated with Levilactobacillus brevis SJC120
por: Silva, Sofia P. M., et al.
Publicado: (2023)

Optimization, fractional characterization, and antioxidant potential of exopolysaccharides from Levilactobacillus brevis NCCP 963 isolated from “kanji”
por: Afreen, Asma, et al.
Publicado: (2023)

The synergistic effect of Levilactobacillus brevis IBRC-M10790 and vitamin D3 on Helicobacter pylori-induced inflammation
por: Nabavi-Rad, Ali, et al.
Publicado: (2023)

Assessment of the feed additive consisting of Levilactobacillus brevis (formerly Lactobacillus brevis) DSM 12835 EU for all animal species for the renewal of its authorisation (Lactosan GmbH & Co KG)
por: Bampidis, Vasileios, et al.
Publicado: (2021)

Probiotic Properties and Antioxidant Activities of Pediococcus pentosaceus SC28 and Levilactobacillus brevis KU15151 in Fermented Black Gamju
por: Yang, Seo Jin, et al.
Publicado: (2020)

Characterisation of recombinant GH 3 β-glucosidase from β-glucan producing Levilactobacillus brevis TMW 1.2112
por: Bockwoldt, Julia A., et al.
Publicado: (2022)

Screening for potential novel probiotic Levilactobacillus brevis RAMULAB52 with antihyperglycemic property from fermented Carica papaya L.
por: Sreepathi, Navya, et al.
Publicado: (2023)

Neuroprotective Effects of Heat-Killed Levilactobacillus brevis KU15152 on H(2)O(2)-Induced Oxidative Stress
por: Bock, Hyun-Ji, et al.
Publicado: (2023)

Evaluation of Different Activity of Lactobacillus spp. against Two Proteus mirabilis Isolated Clinical Strains in Different Anatomical Sites In Vitro: An Explorative Study to Improve the Therapeutic Approach
por: Fusco, Alessandra, et al.
Publicado: (2023)

Potential of Biofermentative Unsulfated Chondroitin and Hyaluronic Acid in Dermal Repair
por: D’Agostino, Antonella, et al.
Publicado: (2022)

Transcriptomics reveal different metabolic strategies for acid resistance and gamma-aminobutyric acid (GABA) production in select Levilactobacillus brevis strains
por: Banerjee, Sagarika, et al.
Publicado: (2021)

Inhibition of carbohydrate hydrolyzing enzymes by a potential probiotic Levilactobacillus brevis RAMULAB49 isolated from fermented Ananas comosus
por: Martiz, Reshma Mary, et al.
Publicado: (2023)

Differential Secretome Profiling of Human Osteoarthritic Synoviocytes Treated with Biotechnological Unsulfated and Marine Sulfated Chondroitins
por: Russo, Rosita, et al.
Publicado: (2020)

Timely Supplementation of Hydrogels Containing Sulfated or Unsulfated Chondroitin and Hyaluronic Acid Affects Mesenchymal Stromal Cells Commitment Toward Chondrogenic Differentiation
por: Alessio, Nicola, et al.
Publicado: (2021)

Development and Optimization of Black Rice (Oryza sativa L.) Sourdough Fermented by Levilactobacillus brevis LUC 247 for Physicochemical Characteristics and Antioxidant Capacity
por: Lai, Syue-Fong, et al.
Publicado: (2023)

Levilactobacillus brevis, autochthonous to cucumber fermentation, is unable to utilize citric acid and encodes for a putative 1,2-propanediol utilization microcompartment
por: Pérez-Díaz, Ilenys M., et al.
Publicado: (2023)

Optimizing Levilactobacillus brevis NPS-QW 145 Fermentation for Gamma-Aminobutyric Acid (GABA) Production in Soybean Sprout Yogurt-like Product
por: Zhang, Yue, et al.
Publicado: (2023)

Microbioreactor (micro‐Matrix) potential in aerobic and anaerobic conditions with different industrially relevant microbial strains
por: D'ambrosio, Sergio, et al.
Publicado: (2021)

Hyaluronic acid and chondroitin sulfate, alone or in combination, efficiently counteract induced bladder cell damage and inflammation
por: Stellavato, Antonietta, et al.
Publicado: (2019)

Molecular Fingerprint of Human Pathological Synoviocytes in Response to Extractive Sulfated and Biofermentative Unsulfated Chondroitins
por: Vassallo, Valentina, et al.
Publicado: (2022)

In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model
por: Stellavato, Antonietta, et al.
Publicado: (2018)

Correction to: In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model
por: Stellavato, Antonietta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_80s6i4o7ngj7h8ffoik6nir6ob